{
    "clinical_study": {
        "@rank": "10088", 
        "acronym": "ME01", 
        "arm_group": {
            "arm_group_label": "Metformin", 
            "arm_group_type": "Experimental", 
            "description": "Metformin 750mg(D1), Metformin 500mg(D2)"
        }, 
        "brief_summary": {
            "textblock": "This study aims to investigate the pharmacokinetics/pharmacodynamics metformin IR after oral\n      administration in healthy elderly male volunteers."
        }, 
        "brief_title": "Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly", 
        "condition": "Healthy Elderly", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males aged 65-85 years with a body mass index (BMI) of 18-28 kg/m2\n\n          -  Good health based on complete medical history, physical examinations, vital signs,\n             electrocardiography (ECG), and clinical laboratory evaluations including hematology\n             (blood cell count, hemoglobin, and platelet count), liver function test (aspartate\n             aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin), serum\n             creatinine, blood glucose and urinalysis\n\n        Exclusion Criteria:\n\n          -  If they had clinically relevant disorders\n\n          -  Past history of diabetes or clinical findings to suspect diabetes\n\n          -  Abnormal clinical laboratory values (i.e., platelets \u2264 75,000/mm3, hemoglobin \u2264 9\n             g/dL, neutrophils absolute \u2264 1000/mm3, fasting glucose > 126mg/dL, creatinine \u2265 1.5\n             mg/dL, or AST, ALT > 3 \u00d7 upper limit of normal)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02125305", 
            "org_study_id": "ME01"
        }, 
        "intervention": {
            "arm_group_label": "Metformin", 
            "intervention_name": "Metformin", 
            "intervention_type": "Drug", 
            "other_name": "Diabex"
        }, 
        "intervention_browse": {
            "mesh_term": "Metformin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metformin", 
            "Pharmacokinetics/ Pharmacodynamics"
        ], 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase I Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in Elderly Healthy Male Volunteers", 
        "overall_official": {
            "affiliation": "Department of Clinical Pharmacology and Therapeutics, Seoul National University Bundang hospital", 
            "last_name": "Jae-Yong Chung, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "AUC(area under the plasma concentration-time curve), Cmax(maximum plasma concentration), t1/2", 
            "measure": "AUC(area under the plasma concentration-time curve)", 
            "safety_issue": "No", 
            "time_frame": "Predose and 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12h postdose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125305"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Jae Yong Chung", 
            "investigator_title": "M.D., Ph.D", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "AUG (total area under the serum concentration-time curve for glucose) Gmax(maximum serum glucose concentration)", 
            "measure": "AUGC(total area under the serum concentration-time curve for glucose concentration)", 
            "safety_issue": "No", 
            "time_frame": "predose and 15, 30, 45, 60, 90, 120 min oral glucose tolerance test"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}